Europe’s bull market still has legs

The pan-European Stoxx Europe 600 index has slipped from May’s two-year peak in recent weeks. But investors shouldn’t worry. There is scope for further gains.

The pan-European Stoxx Europe 600 index has slipped from May's two-year peak in recent weeks. But investors "shouldn't be too nervous", says The Wall Street Journal's Richard Barley. There is scope for further gains.

The economic recovery is gradually gathering momentum, with the single-currency area set to expand by an "impressive" 0.7% in the second quarter alone, says Chris Williamson of IHS Markit. The composite PMI index, tracking both manufacturing and services, remains close to a six-year high. Eurozone exports, and the region's overall trade surplus, have reached new records. The continent is more exposed to the global economy than the US or Japan, so it will benefit most from the improving worldwide outlook. Germany's widely watched Ifo business confidence indicator has reached its highest level since 1991.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up
Andrew Van Sickle
Editor, MoneyWeek

Andrew is the editor of MoneyWeek magazine. He grew up in Vienna and studied at the University of St Andrews, where he gained a first-class MA in geography & international relations.

After graduating he began to contribute to the foreign page of The Week and soon afterwards joined MoneyWeek at its inception in October 2000. He helped Merryn Somerset Webb establish it as Britain’s best-selling financial magazine, contributing to every section of the publication and specialising in macroeconomics and stockmarkets, before going part-time.

His freelance projects have included a 2009 relaunch of The Pharma Letter, where he covered corporate news and political developments in the German pharmaceuticals market for two years, and a multiyear stint as deputy editor of the Barclays account at Redwood, a marketing agency.

Andrew has been editing MoneyWeek since 2018, and continues to specialise in investment and news in German-speaking countries owing to his fluent command of the language.